A Win For Virax Biolabs Group Limited
Fri, Aug 16, 2024 at 07:22 PM
Virax Biolabs Group Limited (VRAX:NASDAQ) rocketted at $2.13, a gain of 53.2%. On Fri, Aug 16, 2024, VRAX:NASDAQ hit a New 2-Week High of $2.13. The stock got featured on our News Catalysts scanner on Fri, Aug 16, 2024 at 04:32 AM in the 'PUBLIC OFFERING' category. From Fri, Aug 02, 2024, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Thu, Jun 06, 2024 at $2.8 with a volume of 79M+.
About Virax Biolabs Group Limited (VRAX:NASDAQ)
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases with a particular interest in the field of...
Top 10 Gainers:
- Cingulate Inc. (CING:NASDAQ), 268.54%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 78.22%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 60.27%
- Seelos Therapeutics, Inc. (SEEL:NASDAQ), 59.52%
- Virax Biolabs Group Limited (VRAX:NASDAQ), 53.24%
- Inspirato Inc Cl A (ISPO:NASDAQ), 40.69%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 40.63%
- Vroom Inc. (VRM:NASDAQ), 34.83%
- Lumos Pharma, Inc. (LUMO:NASDAQ), 33.47%
- Yoshiharu Global Co. (YOSH:NASDAQ), 32.77%